Archive for the ‘Detoxing’ Category

Dr. Todd Lepine – Functional Medicine and Lyme Disease

  Published on Jul 20, 2017

Dr. Jay Davidson interviews functional medicine expert, Dr. Todd LePine.  They walk through Lyme disease, parasites, the importance of mitochondria, nutrition, infrared technology, parasites, and much more!

Show Details:

1:12 – Dr. Todd LePine’s Background
5:50 – Top Testing Dr. LePine Uses for his Functional Medicine Approach
8:25 – Dr. LePine’s Preferred Lyme Disease Specific Testing
11:00 – Genetic Testing
14:40 – Mitochondria and Your Health
17:15 – Courtagen- Genetic Testing Related to Mitochondria
18:10 – Exercise and Nutrition Impacting Your Mitochondria
20:00 – PQQ Supplement for Mitochondria
20:40 – Mitochondria as Bacteria
21:30 – Evolution of Nutrition and Cycling Your Diet
25:30 – Intermittent Fasting
25:30 – Circadian Rhythm
28:55 – Lyme Disease aka “Tick-Bourne Illness”
32:45 – The Role of Antibiotics in Lyme
36:25 – Probiotics
38:30 – Parasites
40:10 – Treatments and Protocols for Lyme
42:15 – Chronic Lyme and Lack of Fevers
43:30 – Infrared Therapy
44:15 – Book Recommendation by Dr. LePine: Plague Time: The New Germ Theory of Disease
45:00 – Chronic Conditions and the Immune System
45:50 – Last Thoughts from Dr. Lepine on Lyme Disease: “The Great Mimicker”
48:30 – Visit Dr. LePine’s Website: or additional educational resources at: Genova Diagnostics —

Chronic LD Summit #2  Please register at link.

Lyme disease is quickly spreading across the entire globe — very few are enlightened on this troublesome condition — that’s why Dr. Jay Davidson has urgently created the second summit on this topic (with only 2 repeat speakers from 2016). 300,000+ people per year contract Lyme, and 2017 is predicted by some to be an incredibly risky year!

The Chronic Lyme Disease Summit 2 is online and FREE from June 19-26, 2017.

Speakers and Topics:

Wayne Anderson, ND
Overview of Lyme and Its Evolution

James Maskell
Evolution of Medicine and Lyme

Scott Forsgren, FDN-P
Maximizing Lyme Disease Recovery

Philip Blair, MD
Col. US Army, ret.
Lyme Recovery with CBD

Jay Davidson, DC, PScD
Improving Lyme Disease Protocols

Jonathan Streit, DC
Testing for Functional Neurological Issues

Tyna Moore, ND, DC
Strength Training to Optimize Stem Cells

Sarah Ballantyne, PhD
Diet/Lifestyle as a Complementary Approach

Leslie Douglas, PhD
DNA Connexions PCR Assay

Greg Lee, MAc, BS
GoodbyeLyme™ Treatments and Remedies

Dave Ou, MD
Things Missed in the Treatment of Lyme

Evan H. Hirsch, MD, ABOIM
Coinfection Bartonella Treatment

Katie Dahlgren, ND
Helping Lyme Through Parasites

Shayne Morris, PhD, MBA, CNS
The Omics of Borrelia
Dietrich Klinghardt, MD, PhD
Latest on Lyme Testing and Treatments

Amy Derksen, ND
Non-Antibiotic Approaches to Treating Children

Dan Pompa, DPSc
Is Chronic Lyme Linked to Heavy Metals?

Todd Watts, DC
Killing Parasites to Kill Lyme Disease

Isaac Eliaz, MD, MS, LAc
Biofilm and Galectin-3 Breakthrough Strategies

Darin Ingels, ND
Herbal Therapy and Low Dose Immunotherapy (LDI)

Jerod Bergman, DC, CCSP, CSCS
Stopping EMFs and Geopathic Stress

Izabella Wentz, PharmD, FASCP
Thyroid and Lyme Disease

Tim Jackson, DPT, CNS(c)
Mitochondrial Dysfunction and Inflammatory Cytokines

Joette Calabrese, HMC, CCH, RSHom
Homeopathic Approach to Lyme Disease

David A. Jernigan, DC
Unique Approach to Healing

Gerry Curatola, DDS
Microbiome of Your Mouth

Jonathan Landsman
Fixing Toxic Teeth and Gums

Jill Carnahan, MD, ABFM, ABIHM, IFMCP
CIRS and Lyme Disease

Christine Schaffner, ND
Healing Your Brain from Lyme Disease

Diane V. Capaldi, MAP
Consciousness as It Relates to Healing

Jon Butcher
Repairing Relationships After Illness

Keesha Ewers, PhD, ARNP
Feeling Betrayed by Your Body?

Kim D’Eramo, DO
Mindsets That Impair Immune Function

Dana Walsh & Brent Martin
How to Lyme Less and Live More!

Sarah Schlichte Sanchez
Fighting as a Mindset

MiraLAX & Behavioral Issues in Children“>

ABC 7 Eyewitness News Video News report

By Wendy Saltzman

Tuesday, February 28, 2017 11:38AM
An Action News Investigation making national headlines has revealed parents’ concerns that a popular over the counter medication is sickening kids.

Following our report, we heard from families across the country who are also voicing claims that their children have developed neuro-psychiatric problems and other troubling side effects after taking MiraLAX.

Lots of parents have reached out to us asking what to do, desperate for answers, because some say after their children were prescribed MiraLAX off label, the behavioral issues started – from depression to anger, anxiety and mood swings.

Now, we have some answers from the experts, including new details on the Children’s Hospital of Philadelphia study, and resources where parents can turn.

“I didn’t feel like a normal kid,” Nicole Oerkfitz from North Wales, Pa. told Action News.

Oerkfitz was placed on MiraLAX when she was just 3-1/2 years old.

“I would be very aggressive towards my sister; I would want to kill my sister, and I was 4,” Oerkfitz said.

Her mother Jeanie Ward said she was horrified to see her once care-free daughter change drastically after she says she took MiraLAX for just ten days.

“Near psychiatric events with paranoia, mood swings, aggression, rage, the OCD repetitive chewing,” Ward said.

It was similar to the stories other families shared with Action News, after they say doctors prescribed MiraLAX off label to treat their children’s constipation.

“After six days on MiraLAX, we noticed overnight he acted out of character,” parent Sarah Locatelli said.

As Action News reported, MiraLAX is made up of Polyethylene Glycol or PEG 3350. The label says for use in “adults and children 17 years of age and older” and for “no more than 7 days.”

But our investigation found many doctors prescribe MiraLAX for young kids, and in some cases for long term use.

Now, doctors at CHOP are speaking out to Action News for the first time, defending the safety of MiraLAX.

“Since MiraLAX came out, we found it so effective, currently it is the go to medication to start with,” CHOP pediatric gastroenterologist Dr. Ritu Verma said.

Dr. Verma admits some of her own patients have claimed their children experienced concerning side effects from the medication, but she says there is no evidence as of yet that it causes any harm.

“We do not at this time have any information at all to say that this is an unsafe medication,” Verma said.

The FDA previously told Action News there was “insufficient data to demonstrate a link between PEG 3350 and serious neuropsychiatric issues in children”citing only 167 adverse events reported to the FDA.

But we dug through a 3,900 page document of 14,688 adverse event reports through 2016 and found more than five times as many. The FDA’s own records actually document 950 children who have reported adverse events to the FDA after taking MiraLAX, ranging from mouth ulcers, to suicidal thoughts, mood swings, aggression and seizures.

The Administration confirmed these numbers, but says there are several limitations including that adverse event reports don’t necessarily prove a relationship between the product and the event. And said, “the FDA has considered these reports…and at this time does not believe additional warnings or other changes are warranted.”

“If a parent is extremely concerned about the side effects of MiraLAX or any other medication, they should stop the medicine,” Verma said.

Osteopathic pediatrician, Dr. Kristen Berry, says she’s anxious to see the results of CHOP’s study.

“We should not be using something off label that’s not approved in children. I definitely have a great concern over that,” Berry said.

CHOP wouldn’t talk about the $325,000 study they are conducting for the FDA, which was commissioned back in 2014.

But to our surprise, apparently it hasn’t started yet.

After our report, they published a statement online, which says, “Researchers…have not begun enrolling children, but once enrollment begins, an announcement will be made.”

“To me, there is definitely what I would call a red flag,” civil attorney Derek Braslow told Action News.

Braslow says he is now reviewing more than 500 families’ claims and is considering filing a lawsuit against Bayer, the maker of MiraLAX.

“The manufacturer has a duty to give an adequate and fair warning of what the benefits of the drug are, and what the risks of the drug are and if they are not doing that then they are liable,” Braslow said.

But for now, for the families we spoke with, questions still remain.

“The rage lasted about 13 years, like it just stopped,” Oerkfitz said.

Oerkfitz, now 19, says the side effects – anger, paranoia, and anxiety – have just recently subsided. And while her memories are filled with pain, she hopes other families will think twice before giving their children MiraLAX.

“I don’t feel like I got to live a normal childhood,” Oerkfitz said.

Bayer previously told Action News there have been many clinical studies conducted with PEG 3350 in pediatric populations which have demonstrated safety for short and long term use in children.

Link to CHOP study:

FDA Statement:

Response to your question on adverse events reported to the FDA:
It is important to note that over-the-counter products containing PEG 3350 are not labeled for use in pediatric patients (other than to direct parents to consult a doctor) or for extended periods of time. However, the agency has undertaken comprehensive reviews of adverse event reports and medical literature. These reviews have indicated that the approved labeling for PEG 3350 products accurately conveys their risks, and additional warnings regarding neuropsychiatric issues in children are not warranted at this time. However, we understand that many parents and physicians rely on these products to treat serious constipation. Because the FDA takes the health and welfare of pediatric populations very seriously, the agency is funding research at Children’s Hospital of Philadelphia (CHOP) to better determine the benefits and risks associated with the use of these products in children. The study is ongoing.

With respect to adverse events, the FDA confirms that, as found in the provided FOIA report which dates up to September 16, 2016, there are nearly 1,100 reports of adverse events in FAERS referencing MiraLAX and pediatric patients. However, it is important to understand that adverse event reports (FAERS data) do have limitations. First, there is no certainty that the reported event was actually due to the product. For a safety report, the FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to fully evaluate an event. Reports are often duplicates or updates of previously reported events, and therefore a raw count of reports may not accurately convey the number of unique events that have actually been reported to FDA. Further, the FDA does not receive all adverse event reports that occur with a product. Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about a drug or event. Therefore, FAERS cannot be used to calculate the incidence of an adverse event in the U.S. population. In addition, while adverse event reports give us some information about a product and serious injuries or deaths related to use of a particular product, they often indicate situations that require additional analysis and do not constitute conclusive evidence of a problem with the product. Sometimes after further analysis, the adverse events may inform agency decisions to take regulatory action. Other times, further analysis shows that the adverse events were not attributable to a problem with the product but to other factors, such as a patient’s underlying health conditions. It also is important to note that the number of adverse events identified may fluctuate with our growing understanding of an issue, as well as through identification and elimination of duplicate reports.

For more information regarding FAERS:

As mentioned above, the FDA has considered these reports as part of its review and at this time does not believe additional warnings or other changes are warranted. We look forward to results of the CHOP study, to further determine the benefits and risks associated with the use of these products in children.

I also refer you to the previous responses FDA has provided you, and the FDA’s response to the 2012 Citizen Petition from the Empire State Consumer Project, available at!documentDetail;D=FDA-2012-P-0566-0006


For information on how to submit an adverse event, see here:
Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of medical products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program:
Complete and submit the report Online:
Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178


Bayer Consumer Health has a long history as a leader in the manufacture and marketing of a broad range of over-the-counter (OTC) healthcare products and nutritional supplements. The health of our consumers is our top priority.

The MiraLAX brand became part of Bayer’s OTC portfolio in the United States in October 2014 with the acquisition of Merck Consumer Care. MiraLAX is an osmotic laxative that relieves occasional constipation. MiraLAX was introduced as a prescription laxative in February 1999 and was approved by the FDA as an OTC medication in 2006. OTC labeled dosing applies to adults and children 17 years and older for up to 7 days, unless otherwise directed by a doctor.

While MiraLAX is not labeled for use in the pediatric population, there have been many clinical studies conducted with PEG 3350 in pediatric populations which have demonstrated safety for short and long term use in children with a history of chronic constipation.

As part of Bayer’s ongoing commitment to consumer well-being, we regularly track, analyze and report all adverse event data related to the use of the product. Results of this ongoing monitoring support the continued safe use of MiraLAX.

With regard to the clinical study in question, it is a government-funded study by the National Institute of Health being conducted by the Children’s Hospital of Philadelphia. As Bayer is not involved in the study, any inquiries should be directed to them.

Aluminum, Alzheimer’s, & LD

Although a strong link between aluminum and Alzheimer’s is fairly well known, a recent study confirms it once again.  Chris Exley, a member of the research group, states that in his view;

“The findings are unequivocal in their confirmation of a role for aluminum in some if not all Alzheimer’s disease.”

He also states that those with familial Alzheimer’s have some of the highest levels ever measured that are similar to fatal cases of aluminum-induced encephalopathy in patients also undergoing renal dialysis.

While this information is important for everyone to know, it is particularly import for Lyme/MSIDS (multi systemic infectious disease syndrome – or Lyme with friends) patients as there is a connection between Alzheimer’s and Lyme Disease as well as other infections.,,

Published on Jun 9, 2016
Dr. Marc Siegel explains on ‘Fox & Friends’ how Kris Kristofferson was diagnosed with Alzheimer’s but actually had Lyme Disease.
(Warning:  the news reporter propagates a myth that “One antibiotic,” prophylactically will cure LD if used early.

The Take Home:  One or two pills of doxycycline will not cure LD.

What is aluminum in and how can we avoid it?

Most Vaccines: (Hepatitis A, B, Hib, DTaP, pneumococcal, Gardasil, and others.) Aluminum is added as an adjuvant that when mixed with a viral or bacterial antigen creates a greater inflammatory immune response which theoretically elicits a higher response of protective antibodies. The problem with this, according to Dr. Mercola, is that vaccines containing inactivated microbes promote antibody-mediated (Th2) immunity which means your body is less prepared to fight infections and more apt to acquire allergies. (Read this well written article about how vaccines work)

According to Dr. Mercola, aluminum injected into a muscle is 100% absorbed by the body, whereas, when ingested it 2-1.5% is absorbed. Also, there seems to be no upper limit in the vaccine program, with the number of aluminum containing vaccines quadrupling over the past 30 years.

The truly frightening aspect of vaccines is that studies have shown that immediately after vaccine injection, macrophages race to eat up the aluminum and the antigen and have the ability to go right through the blood brain barrier into the brain like a Trojan horse – delivering aluminum directly to the brain. This, if you remember, is what Exley warns about – an accumulation of aluminum in the brain – which is a part of the perfect storm of Alzheimer’s. Adding to the perfect storm are infections such as tick borne infections, inflammation (which TBI’s also cause), mitochondrial problems (TBI’s can cause), dysbiosis (think “leaky gut” which TBI’s can cause as well as yeast/fungus due to antibiotic use), premature birth, irradiation, infant formulas, and methamphetamines.

Antiperspirants: Aluminum (chloride, chlorohydrate, zirconium) salts can make up 25% of some antiperspirants, and after a single application about .012% of aluminum may be absorbed. The tally over a life-time of use is huge.   Look in your health food store for alternatives or take a pinch of baking soda mixed into water and apply to underarms.

Food supply:  Aluminum compounds are often added into foodstuffs as well as by contamination with aluminum equipment. Baking powder, self rising flour, salt, baby formula, coffee creamers, baked goods and processed foods, coloring and caking agents often have aluminum. Read labels. Cooking in aluminum foil increases concentration. Avoid aluminum laminated pouch drinks.

Drugs: antacids, analgesics, anti-diarrheals and additives like magnesium stearate.

Toothpaste: read labels and avoid aluminum oxyhydroxide.

Aluminum Cookware and aluminum espresso makers

Chelating agents to detoxify Aluminum:, by Dr. Mercola (March 22, 2014)

Silica-rich water, such as Fiji water,17 which contains 83 Mg of silica per liter. Research published in 2013 showed that drinking up to one liter of a silicon-rich mineral water daily for 12 weeks effectively excreted aluminum via the urine, without detrimental effects on essential metals such as iron and copper. According to the authors: “We have provided preliminary evidence that over 12 weeks of silicon-rich mineral water therapy the body burden of aluminum fell in individuals with Alzheimer’s disease and, concomitantly, cognitive performance showed clinically relevant improvements in at least 3 out of 15 individuals.”
• Melatonin: Research shows that melatonin has a metal binding role and is a useful supplement in the treatment of neurological disorders in which oxidative stress is involved, which includes Alzheimer’s. Melatonin can travel freely across all cellular barriers, facilitating the removal of toxic metals such as aluminum. It also appears to suppress the oxidative activity of aluminum in your brain.
• Anything that raises your glutathione. Your body synthesizes glutathione from three amino acids: cysteine, glutamate, and glycine. Raw fruits and vegetables, particularly avocado, asparagus, grapefruit, strawberries, orange, tomato, cantaloupe, broccoli, okra, peach, zucchini, and spinach are rich in the precursors glutamate and glycine. Dietary sources of cysteine include eggs, meat, red peppers, garlic, onions, Brussels sprouts, whey protein, and wheat germ. Other helpful treatments for improved glutathione metabolism include:
Exercise: Exercise affects your adenosine triphosphate (ATP) levels needed to help produce glutathione
Optimizing your vitamin D levels through sun exposure: There’s some evidence vitamin D increases intracellular glutathione levels
Epsom salt baths
MSM supplementation
◦ The supplement N-acetyl L-cysteine (NAC) may also be useful. NAC is the rate-limiting nutrient for the formation of the intracellular antioxidant glutathione
Curcumin: Research suggests that curcumin has a protective effect against aluminum-induced damage by modulating the extent of oxidative stress. It also decreases beta-amyloid plaques associated with Alzheimer’s, delays neuron degradation, chelates metals, decreases microglia formation, and has an overall anti-inflammatory, antioxidant effect. Studies have shown that curcumin can help improve memory in Alzheimer’s patients. There are some contraindications that curcumin is not recommended if you have biliary tract obstruction (as it stimulates bile secretion), gallstones, obstructive jaundice, or acute biliary colic.

LD Therapies – Dr. Rawl

  Approx. 1 Hour

Published on Dec 8, 2016

Last weekend, Dr. Rawls gave a presentation titled Exploring Lyme Disease Therapies in the 21st Century to the North Carolina Lyme Foundation.  What you’ll learn from this video lecture:

– 6 components necessary for recovery
– 3 holistic approaches to overcoming Lyme
– The importance of immune function on the body
– My approach to boosting the immune system and regaining lost health

For more information, please visit

Immune Support Talk

  Approx. 1 hour

Made possible by Minnesota Lyme Association

Excellent presentation on Immune Support for Chronic Lyme Disease by Dr. Radovsky

The Detox Project

Dr. Jay Davidson is hosting a free on-line summit called The Detox Project from September 26th – October 3 2016.  You can sign up by clicking the link above.

MSIDS sufferers require treatment that not only kills pathogens but is also able to clear these dead pathogens from the body.  This is where detoxing comes into play.  While the mainstream medical community views detoxing as quackery, those of us infected understand quite up close and personal the Herxheimer Reaction where we have an autoimmune type response when our immune system finally recognizes the dead pathogens floating around in our blood stream.  For more information on the Herxheimer Reaction see:

Also, for those who are new to all of this, please read: